CY2013024I2 - Παραγωγα στυρυλοπυριδινης και η χρηση τους για συνδεση κι απεικονιση πλακων αμυλοειδους - Google Patents

Παραγωγα στυρυλοπυριδινης και η χρηση τους για συνδεση κι απεικονιση πλακων αμυλοειδους

Info

Publication number
CY2013024I2
CY2013024I2 CY2013024C CY2013024C CY2013024I2 CY 2013024 I2 CY2013024 I2 CY 2013024I2 CY 2013024 C CY2013024 C CY 2013024C CY 2013024 C CY2013024 C CY 2013024C CY 2013024 I2 CY2013024 I2 CY 2013024I2
Authority
CY
Cyprus
Prior art keywords
styrylopyridine
derivatives
binding
amyloid plaques
imaging amyloid
Prior art date
Application number
CY2013024C
Other languages
English (en)
Other versions
CY2013024I1 (el
Original Assignee
The Trustees Of The University Of Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Trustees Of The University Of Pennsylvania filed Critical The Trustees Of The University Of Pennsylvania
Publication of CY2013024I1 publication Critical patent/CY2013024I1/el
Publication of CY2013024I2 publication Critical patent/CY2013024I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94—Oxygen atom, e.g. piperidine N-oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY2013024C 2006-03-30 2013-06-27 Παραγωγα στυρυλοπυριδινης και η χρηση τους για συνδεση κι απεικονιση πλακων αμυλοειδους CY2013024I2 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78715606P 2006-03-30 2006-03-30
PCT/US2007/007400 WO2007126733A2 (en) 2006-03-30 2007-03-26 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques

Publications (2)

Publication Number Publication Date
CY2013024I1 CY2013024I1 (el) 2015-11-04
CY2013024I2 true CY2013024I2 (el) 2015-11-04

Family

ID=38326579

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20121100225T CY1113048T1 (el) 2006-03-30 2012-03-07 Παραγωγα στυρυλοπυριδινης και η χρηση τους για συνδεση κι απεικονιση πλακων αμυλοειδους
CY2013024C CY2013024I2 (el) 2006-03-30 2013-06-27 Παραγωγα στυρυλοπυριδινης και η χρηση τους για συνδεση κι απεικονιση πλακων αμυλοειδους
CY20171100664T CY1119048T1 (el) 2006-03-30 2017-06-22 Παραγωγα στυρυλοπυριδινης και η χρηση τους για συνδεση κι απεικονιση πλακων αμυλοειδους

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20121100225T CY1113048T1 (el) 2006-03-30 2012-03-07 Παραγωγα στυρυλοπυριδινης και η χρηση τους για συνδεση κι απεικονιση πλακων αμυλοειδους

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20171100664T CY1119048T1 (el) 2006-03-30 2017-06-22 Παραγωγα στυρυλοπυριδινης και η χρηση τους για συνδεση κι απεικονιση πλακων αμυλοειδους

Country Status (34)

Country Link
US (3) US7687052B2 (el)
EP (3) EP2363391A1 (el)
JP (1) JP5290954B2 (el)
KR (1) KR101376807B1 (el)
CN (1) CN101522624B (el)
AT (1) ATE539060T1 (el)
AU (1) AU2007243712B2 (el)
BR (1) BRPI0710225B1 (el)
CA (1) CA2644530C (el)
CR (1) CR10329A (el)
CY (3) CY1113048T1 (el)
DK (2) DK1999109T3 (el)
EA (1) EA017898B1 (el)
EC (1) ECSP088783A (el)
ES (2) ES2628882T3 (el)
FR (1) FR13C0034I2 (el)
GT (1) GT200800201A (el)
HR (2) HRP20120135T1 (el)
HU (2) HUE032660T2 (el)
IL (1) IL193567A (el)
LT (1) LT2363392T (el)
LU (1) LU92232I2 (el)
MX (1) MX2008012527A (el)
NO (2) NO342090B1 (el)
NZ (1) NZ570887A (el)
PL (2) PL1999109T3 (el)
PT (2) PT1999109E (el)
RS (2) RS56171B1 (el)
SG (1) SG173338A1 (el)
SI (2) SI1999109T1 (el)
TW (1) TWI399366B (el)
UA (1) UA97802C2 (el)
WO (1) WO2007126733A2 (el)
ZA (1) ZA200807955B (el)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1999109T1 (sl) 2006-03-30 2012-04-30 Univ Pennsylvania Derivati stirilpiridina in njihova uporaba za vezavo in prikazovanje amiloidnih plakov
JP5322180B2 (ja) * 2007-07-04 2013-10-23 国立大学法人東北大学 フッ素およびヒドロキシ基で置換されたアルコキシ基を有するｐｅｔプローブ
JP5603855B2 (ja) 2008-04-04 2014-10-08 アビッド レディオファーマシューティカルズ、インク． 神経変成疾患の放射性薬剤による画像化
BRPI0923890A2 (pt) * 2008-12-31 2015-07-28 Avid Radiopharmaceuticals Inc Síntese de estilpiridinas 18f- radiomarcadas a partir de percussores tosilatos de composições farmacêuticas estáveis do mesmo.
KR20120034724A (ko) * 2009-07-10 2012-04-12 바이엘 파마 악티엔게젤샤프트 저압 내지 중간압 액체 크로마토그래피의 사용에 의한 방사성추적자의 정제
WO2011045415A2 (en) 2009-10-15 2011-04-21 Guerbet New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
CN102762229B9 (zh) * 2009-12-23 2020-12-01 皮拉马影像股份公司 适用于用疏水pet试剂pet成像的配方
WO2011141515A1 (en) 2010-05-14 2011-11-17 Bayer Pharma Aktiengesellschaft Diagnostic agents for amyloid beta imaging
SI2579902T2 (sl) 2010-06-04 2019-10-30 Life Molecular Imaging Sa Postopek za izdelavo amiloidnih beta ligandov, označenih s F-18
TWI504414B (zh) 2010-06-04 2015-10-21 Bayer Schering Pharma Ag 生產Ｆ－１８標記之Ａβ配位體之方法
WO2011151281A1 (en) * 2010-06-04 2011-12-08 Bayer Pharma Aktiengesellschaft Method for production of f-18 labeled amyloid beta ligands
AU2011260420A1 (en) 2010-06-04 2013-01-10 Piramal Imaging Sa Method for production of F-18 labeled amyloid beta ligand
CN101891674B (zh) * 2010-06-24 2012-11-14 山东大学 4-苯乙烯基吡啶类化合物及其制备方法与应用
WO2012051170A2 (en) * 2010-10-12 2012-04-19 Mayo Foundation For Medical Education And Research Imaging of meningiomas using phingylbenzothiazole, stilbene, or biphenylalkyne derivatives
US20140079635A1 (en) * 2011-03-30 2014-03-20 Case Western Reserve University Molecular probes for detecting lipid composition
JP6038122B2 (ja) 2011-04-21 2016-12-07 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 機能性磁性ナノ粒子、ならびにアミロイド沈着物および神経原繊維濃縮体の画像処理における使用
JP2015501305A (ja) 2011-10-19 2015-01-15 ピラマル イメージング ソシエテ アノニム Ｆ‐１８標識Ａβリガンドの改良された製造方法
CN104244991A (zh) 2012-04-10 2014-12-24 蓝瑟斯医学影像公司 放射性药物合成方法
JP6099045B2 (ja) * 2013-04-30 2017-03-22 国立大学法人京都大学 トリアゾロピリミジン誘導体化合物
JP2014218454A (ja) * 2013-05-07 2014-11-20 日本メジフィジックス株式会社 スチリルピリジン誘導体化合物
JP6041751B2 (ja) * 2013-05-07 2016-12-14 日本メジフィジックス株式会社 スチリルピリジン誘導体化合物
CN103645254B (zh) * 2013-11-28 2015-01-07 江苏省原子医学研究所 一种Aβ斑块显像剂前体AV45的含量分析方法
PT3143011T (pt) * 2014-05-13 2021-04-26 Hoffmann La Roche Compostos heterocíclicos deuterados e a sua utilização como agentes de imagiologia
US10478513B2 (en) 2015-08-18 2019-11-19 The Regents Of The University Of Califonia Nitroxide containing amyloid binding agents for imaging and therapeutic uses
US10300155B2 (en) 2015-12-31 2019-05-28 Washington University Alpha-synuclein ligands
CN109400615B (zh) * 2017-08-18 2021-07-16 上海交通大学医学院附属新华医院 一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用
CN108299287A (zh) * 2018-01-02 2018-07-20 北京师范大学 与Aβ斑块具有高亲和力的N2S2类吡啶基苯乙烯化合物
CN114805190A (zh) * 2022-06-08 2022-07-29 吉林大学第一医院 一种甲基苯胺类Aβ蛋白显像剂的双柱合成方法
WO2024107620A1 (en) 2022-11-14 2024-05-23 Eli Lilly And Company Polymorphic forms of florbetapir precursor av-105

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000963A1 (en) 1990-07-12 1992-01-23 Yoshitomi Pharmaceutical Industries, Ltd. Styryl compounds and use thereof as medicine
JPH0545875A (ja) * 1991-08-08 1993-02-26 Konica Corp 感光性組成物
US6020436A (en) * 1993-03-09 2000-02-01 The Chromaline Corporation Photosensitive resin composition
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
WO2001070667A1 (fr) * 2000-03-22 2001-09-27 Bf Research Institute, Inc. Sonde de diagnostic par image, a base d'azobenzene substitue ou d'un analogue de celui-ci, pour les maladies imputables a l'accumulation d'amyloide et composition pour le diagnostic par image le contenant
US8007954B2 (en) 2000-11-09 2011-08-30 The Trustees Of The University Of Pennsylvania Use of sulfur-containing fuels for direct oxidation fuel cells
JP2002182254A (ja) 2000-12-18 2002-06-26 Fuji Photo Film Co Ltd 非線形光学材料とその製造方法
CN1299777C (zh) * 2001-08-27 2007-02-14 宾夕法尼亚州大学理事会 茋衍生物及其用于结合和成像淀粉样蛋白斑的用途
JP2005529464A (ja) 2002-06-06 2005-09-29 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア セラミックアノード及びそれを生産する方法
WO2004016271A1 (en) * 2002-08-14 2004-02-26 Axxima Pharmaceuticals Ag Pyrimidones as antiviral agents
JP4482352B2 (ja) 2004-03-11 2010-06-16 本田技研工業株式会社 固体高分子型燃料電池
WO2006078384A2 (en) * 2004-12-17 2006-07-27 The Trustees Of The University Of Pennsylvania Stilbene derivatives and their use
JP5128956B2 (ja) * 2004-12-17 2013-01-23 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア アミロイドプラークに結合し画像化するためのスチルベン誘導体及びそれらの使用
WO2007002540A2 (en) * 2005-06-24 2007-01-04 Kung Hank F Radiolabeled-pegylation of ligands for use as imaging agents
SI1999109T1 (sl) 2006-03-30 2012-04-30 Univ Pennsylvania Derivati stirilpiridina in njihova uporaba za vezavo in prikazovanje amiloidnih plakov
US20080253967A1 (en) * 2007-04-13 2008-10-16 Kung Hank F Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques

Also Published As

Publication number Publication date
PL2363392T3 (pl) 2017-10-31
EP1999109A2 (en) 2008-12-10
PT1999109E (pt) 2012-03-16
US7687052B2 (en) 2010-03-30
AU2007243712B2 (en) 2013-01-10
IL193567A0 (en) 2009-05-04
JP5290954B2 (ja) 2013-09-18
US20090123369A1 (en) 2009-05-14
DK1999109T3 (da) 2012-04-02
MX2008012527A (es) 2008-10-14
HRP20120135T1 (hr) 2012-03-31
PL1999109T3 (pl) 2012-05-31
PT2363392T (pt) 2017-06-15
EP1999109B1 (en) 2011-12-28
CA2644530C (en) 2015-05-19
UA97802C2 (uk) 2012-03-26
EP2363392B1 (en) 2017-05-03
CN101522624B (zh) 2013-11-06
NO20084590L (no) 2008-12-29
FR13C0034I2 (fr) 2014-03-07
EA200870389A1 (ru) 2009-04-28
US8506929B2 (en) 2013-08-13
LT2363392T (lt) 2017-07-25
KR20080106564A (ko) 2008-12-08
HUE032660T2 (en) 2017-10-30
EA017898B1 (ru) 2013-04-30
HRP20170857T1 (hr) 2017-12-01
TWI399366B (zh) 2013-06-21
EP2363391A1 (en) 2011-09-07
ATE539060T1 (de) 2012-01-15
JP2009532349A (ja) 2009-09-10
LU92232I9 (el) 2019-01-15
CY2013024I1 (el) 2015-11-04
WO2007126733A3 (en) 2008-03-06
SG173338A1 (en) 2011-08-29
EP2363392A1 (en) 2011-09-07
LU92232I2 (fr) 2013-08-26
FR13C0034I1 (el) 2013-08-09
ECSP088783A (es) 2008-10-31
HUS1300028I1 (hu) 2017-08-28
US20080038195A1 (en) 2008-02-14
TW200838852A (en) 2008-10-01
SI2363392T1 (sl) 2017-09-29
ZA200807955B (en) 2012-11-28
CR10329A (es) 2008-10-29
WO2007126733A2 (en) 2007-11-08
BRPI0710225B1 (pt) 2021-07-13
US20130129624A1 (en) 2013-05-23
BRPI0710225A2 (pt) 2011-08-02
NO2018030I1 (no) 2018-09-11
ES2378785T3 (es) 2012-04-17
NZ570887A (en) 2011-05-27
DK2363392T3 (en) 2017-07-03
CY1113048T1 (el) 2015-11-04
US8840866B2 (en) 2014-09-23
SI1999109T1 (sl) 2012-04-30
GT200800201A (es) 2009-08-20
ES2628882T3 (es) 2017-08-04
IL193567A (en) 2014-03-31
CA2644530A1 (en) 2007-11-08
RS52222B (en) 2012-10-31
CN101522624A (zh) 2009-09-02
AU2007243712A1 (en) 2007-11-08
CY1119048T1 (el) 2018-01-10
NO342090B1 (no) 2018-03-19
RS56171B1 (sr) 2017-11-30
KR101376807B1 (ko) 2014-03-20

Similar Documents

Publication Publication Date Title
CY2013024I2 (el) Παραγωγα στυρυλοπυριδινης και η χρηση τους για συνδεση κι απεικονιση πλακων αμυλοειδους
CY2017006I2 (el) Αερολυμενες φθοροκινολονες και χρησεις αυτων
CY2015013I1 (el) Αντι-μολυσματικες πυραμιδινες και χρησεις αυτων
EP2023919A4 (en) COMPOUNDS AND AMYLOID PROBES FOR THERAPY AND IMAGING USES
FI20065267A (fi) Järjestely dentaalikuvausta varten
DE602007002722D1 (de) Bilderzeugungsvorrichtung
EP2144507A4 (en) DIPHENYL-HETEROARYL DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLATES
DE602006011416D1 (de) Bilderzeugungsvorrichtung
DE602006016536D1 (de) Bildaufnahmegerät
ITFI20050094A1 (it) Opercolatrice perfezionata
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
DE602007007545D1 (de) Bilderzeugungsvorrichtung
DE602006000911D1 (de) Bilderzeugungsvorrichtung
IL199201A (en) Acetylene history and their use for linking and imaging of amyloid layers
EP2144916A4 (en) PHENYLNAPHTHALENE DERIVATIVES AND PHENYLQUINOLINES AND THEIR USE FOR THE BINDING AND FORMATION OF AMYLOID PLATE IMAGES
DE602007006585D1 (de) Bilderzeugungsvorrichtung
DE602006006130D1 (de) Bildaufnahmevorrichtung
DE602006006252D1 (de) Bilderzeugungsvorrichtung
DE602007000286D1 (de) Bilderzeugungsvorrichtung
DE602007001904D1 (de) Bilderzeugungsvorrichtung
ZA201102689B (en) Piperazine derivatives for binding and imaging amyloid plaques and their use
DK2029561T3 (da) Tricyclisk forbindelse og farmaceutisk anvendelse deraf
DE102007003843A8 (de) Bilderzeugungseinrichtung
DE602006010763D1 (de) Bilderzeugungsvorrichtung
DE602007005337D1 (de) Bilderzeugungsvorrichtung